John Schick joined Gamida Cell’s leadership team as vice president, market access, in July 2018, bringing more than 25 years of experience in developing and implementing U.S. market access strategies to his role. Prior to joining Gamida Cell, where he served as senior director, payer relations at Kite Pharma, Inc., and was responsible for the development and implementation of tactical strategies to ensure appropriate access to cancer immunotherapy YESCARTA®. Prior to joining Kite, John served as a director at Infinity Pharmaceuticals, Inc., where he led the design, implementation and management of trade, distribution and physician network functions to support the potential launch of the company’s hematology/oncology candidate. John has also held various roles at Onyx Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc. and Allergan plc.
John holds a B.S. in agriculture science from Auburn University.